Form 4: Inspire Medical Systems Exec's Equity Awards

Inspire Medical Systems' Senior VP Bryan K. Phillips reported significant equity awards, including performance stock units and restricted stock units, alongside tax-related share withholdings, effective February 20, 2026.

Summary

• Bryan K. Phillips, Senior Vice President, General Counsel, Secretary, and Chief Compliance Officer of Inspire Medical Systems, Inc. (INSP), reported changes in beneficial ownership.
• On February 20, 2026, Phillips acquired 2,400 shares of common stock as an award following the satisfaction of performance conditions for previously granted performance stock units.
• On the same date, 735 shares of common stock were withheld by the Issuer to satisfy taxes incident to the vesting of a performance stock unit award, at a price of $59.53 per share.
• Phillips also received an award of 15,958 restricted stock units (RSUs) and 8,399 restricted stock units (RSUs) on February 20, 2026.
• These RSUs will vest in three equal annual installments, commencing on February 20, 2027, contingent on Phillips' continuous employment.
• Following these transactions, Phillips beneficially owns a total of 38,513 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine executive compensation event, reflecting continued alignment of management interests with shareholders through equity awards, which is generally a neutral to slightly positive signal.

Positives

• The equity awards (performance stock units and restricted stock units) align the executive's interests with those of shareholders, incentivizing long-term performance.
• The awards demonstrate the company's commitment to retaining key management personnel through competitive compensation packages.

Negatives

• No inherently negative events are reported; the withholding of shares for taxes is a standard procedure associated with equity vesting.

Future Outlook

The filing indicates future vesting events for the restricted stock units, with the first installment scheduled for February 20, 2027, contingent on the reporting person's continued employment.

Industry Context

StockSavvy.ai notes that the granting of performance-based equity awards and restricted stock units is a common practice in the medical technology industry and broader corporate landscape for executive compensation. This strategy aims to align executive incentives with long-term company performance and shareholder value creation.

Stakeholder Impact

• Shareholders: The equity awards align management's long-term interests with shareholder value, potentially fostering greater commitment to company performance.
• Employees: The compensation structure for a senior executive may set a precedent or reflect the company's overall approach to incentivizing key personnel.

Next Steps

• The restricted stock units will vest in three equal annual installments, commencing on February 20, 2027, subject to continuous employment.

Key Dates

Keywords

Inspire Medical Systems, INSP, Form 4, insider transaction, equity award, restricted stock units, performance stock units, executive compensation, beneficial ownership